3d agoThe FlyBULLISH 61Analyst
Archived explainer. For the current picture see today's CLOV page.
Why Is CLOVER HEALTH INVTS A (CLOV) Stock Up Today?
By the Top Tier Newswire AI Desk · September 10, 2026 at 9:45 AM ET · reviewed against 1 wire stories
CLOVER HEALTH INVTS A (CLOV) is up +7.61% in the latest session. Our newswire has captured 1 story on CLOV across 1 source in the last 36 hours, with AI sentiment reading bullish (avg 61/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Clover Health Investments A (CLOV) rose 7.61% to $4.67 in morning trade, driven by a new Buy initiation from Deutsche Bank. The stock opened at $4.36 and reached an intraday high of $4.71 at 9:45 AM ET. The move comes amid recent earnings beats and a raised sales forecast for the year.
What Happened
Deutsche Bank initiated coverage of Clover Health with a Buy rating, marking the only story published on the stock in the last 36 hours. This comes after Clover Health reported second-quarter earnings of $0.05 per share, exceeding the $0.03 estimate, and revenue of $743.167 million, surpassing the $728.267 million forecast. The company also raised its full-year 2026 sales guidance to a range of $2.920B to $3.000B, above the $2.910B estimate. UBS previously raised its price target to $5 while maintaining a Neutral stance.
What The Data Shows
The stock traded at $4.67 in morning trade, with 1.3 million shares changing hands, or 0.2 times the 3-month daily average. The price trend over the last 8 sessions showed a modest gain of 1.3% from $4.23 to $4.28. The stock has a market capitalization of $2.3 billion, with a trailing twelve-month revenue growth of 54.0% and a beta of 2.48. The 52-week range is $1.58 to $5.59. On the insider front, there have been 16 sell transactions totaling $3.1 million in the last 90 days, with the most recent on August 17.
What To Watch
The stock is set to continue trading with heightened attention on its earnings momentum and guidance. Investors may also monitor coverage breadth as the single Buy initiation could influence broader analyst sentiment.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
CLOV by the numbers
Last: $4.67Session: +7.61%7 sessions: +12.40%Coverage: 1 stories / 1 sourcesAI sentiment: 61/100 (bullish)Mkt cap: $2.3B52w: $1.58 to $5.59
The headlines behind the move
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on CLOV: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier CLOV move explainers: 2026-09-11 · 2026-09-10 · 2026-09-01